je.st
news
Mead Johnson Nutrition CO (MJN) Cut to Sell at Zacks Investment Research
2016-01-10 00:47:53| Biotech - Topix.net
According to Zacks, "Mead Johnson posted dismal financial numbers in the third quarter of 2015, missing the Zacks Consensus Estimate of both earnings and revenues.The company's segmental performance was also considerably weak. Moreover, the near-term challenges in its emerging market segments are expected to continue in 2016 as well.
Tags: research
sell
cut
investment
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||